Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
18,32 USD | +1,98 % | +0,91 % | +27,27 % |
Resumen de negocios
Número de empleados: 154
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 03/01/17 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 02/12/19 |
Scott Macke
COO | Chief Operating Officer | - | 01/09/14 |
Jerad G. Seurer
CMP | Compliance Officer | - | 01/01/17 |
Jennifer Gudeman
CTO | Chief Tech/Sci/R&D Officer | - | 07/12/20 |
Jason Vaughn
CTO | Chief Tech/Sci/R&D Officer | - | 02/12/19 |
Denise Strauss
SAM | Sales & Marketing | - | 02/06/21 |
Angela Woods
HRO | Human Resources Officer | - | 01/05/21 |
Richard Kim
PRN | Corporate Officer/Principal | 54 | 15/02/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 01/12/18 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 03/01/17 |
Mark McCamish
BRD | Director/Board Member | 72 | 05/12/19 |
Geoffrey Glass
CHM | Chairman | 50 | 01/07/18 |
Linda Palczuk
BRD | Director/Board Member | 62 | 01/07/18 |
Peter Thornton
BRD | Director/Board Member | 59 | 01/07/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 90 576 998 | 86 139 858 ( 95,10 %) | 0 | 95,10 % |
Acción B | 0 | 5 194 000 | 0 | 0 |
Información de la empresa
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+27,27 % | 1627,67 M | |
+34,09 % | 664 mil M | |
+29,29 % | 567 mil M | |
-7,27 % | 354 mil M | |
+19,04 % | 330 mil M | |
+4,68 % | 286 mil M | |
+13,79 % | 234 mil M | |
+4,93 % | 199 mil M | |
-9,78 % | 196 mil M | |
-4,76 % | 148 mil M |
- Bolsa de valores
- Acciones
- Acción AVDL
- Empresa Avadel Pharmaceuticals plc